Analyst Expectations for Mirum Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
Mirum Pharmaceuticals (NASDAQ:MIRM) has received 7 bullish analyst ratings in the last quarter, with an average price target of $67.0, compared to its current price of $26.7517. The average price target has decreased by 19.76% from the previous average of $83.50.
May 22, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mirum Pharmaceuticals has 7 bullish analyst ratings with an average price target of $67, a significant upside from its current price of $26.7517.
The 7 bullish analyst ratings indicate a positive outlook for Mirum Pharmaceuticals. The average price target of $67 suggests a significant upside potential from the current price of $26.7517. This information is important for investors as it shows that analysts have a positive view on the stock, which could lead to an increase in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100